SPMS trial of Lamotrigine tested for neuroprotection benefit
Posted: Mon Feb 03, 2014 12:59 am
A recently completed study at University College London Hospital suggests that administration of certain drugs can block the entry of sodium ions in nerve cells that in turn can prevent aggressive nerve cell damage. The research team proposed that delaying nerve cell destruction can limit the rate of disability in secondary progressive MS patients. The supporting study, which was completed after two years of testing, was aimed at employing nerve cell blockers like lamotrigine to monitor the rate of worsening disability in secondary progressive MS patients.......... Read More - http://www.ms-uk.org/MStypes